Continuing-Education
The Drug Information Association (DIA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 12 contact hours or 1.2 continuing education units (CEU’s). Type of activity: Knowledge
ACPE CREDIT REQUESTS MUST BE SUBMITTED BY THURSDAY, MAY 28, 2015
DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. If ACPE credit is not requested by Thursday, May 28, 2015, the CEU request will not be transmitted through to the CPE Monitor. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer 1.7 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
DIA’s Certificate Program
This program is part of DIA’s Certificate Program and is awarded the following:
• Project Management Certificate Program: 8 Elective Units
• Regulatory Affairs Certificate Program: 10 Elective Units
For more information go to www.DIAGlobal.org/certificateprograms
CONTINUING EDUCATION PHARMACY ALLOCATION
The following sessions are approved for ACPE credit:
• Session 1: Lifecycle Management: 1.5 contact hours or .15 CEUs; 0286-0000-15-048-L04-P
• Session 2B: Post-Approval Change Management Protocols (PACMP): 1.5 contact hours or .15 CEUs; 0286-0000-15-049-L04-P
• Session 4: Control Strategy Approaches for Drug Substance and Drug Product: 2 contact hours or .2 CEUs; 0286-0000-15-050-L04-P
• Session 5B: Risk-based Review: 1.5 contact hours or .15 CEUs; 0286-0000-15-051-L04-P
• Session 6B: Breakthrough Therapies: 2 contact hours or .2 CEUs; 0286-0000-15-052-L04-P
• Session 6C: Comparability Biologicals: 2 contact hours or .2 CEUs; 0286-0000-15-053-L04-P
• Session 8C: Risk Management for Biologicals: 2 contact hours or .2 CEUs; 0286-0000-15-054-L04-P
• Session 9B: Pediatrics: 1.5 contact hours or .15 CEUs; 0286-0000-15-055-L04-P
• Session 9C: Clinically Relevant Specifications: Technical Considerations and Regulatory Expectations: 1.5 contact hours or .15 CEUs; 0286-0000-15-056-L04-P
| Name | Credit Type | Max Credits | CEU |
| CMC Workshop 2015 | Credit TypeACPE | Max Credits12.00 | CEU1.200 |
| CMC Workshop 2015 | Credit TypeIACET | Max Credits17.25 | CEU1.700 |
Statement of Credit:
If you would like to receive a statement of credit, you must sign in at each session you attend, and complete the on line credit request process through My Transcript. To access My Transcript, please go to www.DIAGlobal.org, select “Login to My DIA” and you will be prompted for your user ID and password. Select “My Transcript” (left side bar) and “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on Wednesday, April 29, 2015.View DIA’s Grievance Policy, at www.DIAGlobal.org/CE.
Have an account?